Abstract |
|
Authors | Shinichi Kako, Yoshinobu Kanda, Kumi Oshima, Nahoko Nishimoto, Hiroyuki Sato, Takuro Watanabe, Noriko Hosoya, Toru Motokura, Shigesaburo Miyakoshi, Shuichi Taniguchi, Aki Kamijo, Koki Takahashi, Shigeru Chiba, Mineo Kurokawa |
Journal | American journal of hematology
(Am J Hematol)
Vol. 83
Issue 3
Pg. 247-9
(Mar 2008)
ISSN: 0361-8609 [Print] United States |
PMID | 17918251
(Publication Type: Case Reports, Journal Article)
|
Copyright | (c) 2007 Wiley-Liss, Inc. |
Chemical References |
- Antibodies, Monoclonal
- Antibodies, Monoclonal, Humanized
- Antibodies, Neoplasm
- Hemoglobins
- Alemtuzumab
|
Topics |
- Alemtuzumab
- Anemia, Hemolytic, Autoimmune
(chemically induced, complications)
- Antibodies, Monoclonal
(adverse effects)
- Antibodies, Monoclonal, Humanized
- Antibodies, Neoplasm
(adverse effects)
- Hematopoietic Stem Cell Transplantation
(adverse effects)
- Hemoglobins
(metabolism)
- Humans
- Male
- Middle Aged
- Myelodysplastic Syndromes
(therapy)
- Red-Cell Aplasia, Pure
(chemically induced, complications)
- Transplantation, Homologous
- Treatment Outcome
|